nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—Abdominal pain upper—Entecavir—hepatitis B	0.0224	0.0242	CcSEcCtD
Ethosuximide—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0187	0.0203	CcSEcCtD
Ethosuximide—Abdominal pain upper—Telbivudine—hepatitis B	0.0184	0.0199	CcSEcCtD
Ethosuximide—Cramp muscle—Telbivudine—hepatitis B	0.0181	0.0196	CcSEcCtD
Ethosuximide—Haematuria—Entecavir—hepatitis B	0.018	0.0195	CcSEcCtD
Ethosuximide—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0175	0.019	CcSEcCtD
Ethosuximide—Abdominal discomfort—Telbivudine—hepatitis B	0.0167	0.0181	CcSEcCtD
Ethosuximide—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0163	0.0177	CcSEcCtD
Ethosuximide—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0162	0.0176	CcSEcCtD
Ethosuximide—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0162	0.0176	CcSEcCtD
Ethosuximide—Immune system disorder—Entecavir—hepatitis B	0.0153	0.0166	CcSEcCtD
Ethosuximide—Mental disorder—Entecavir—hepatitis B	0.0148	0.0161	CcSEcCtD
Ethosuximide—Malnutrition—Entecavir—hepatitis B	0.0147	0.016	CcSEcCtD
Ethosuximide—Aplastic anaemia—Lamivudine—hepatitis B	0.0147	0.0159	CcSEcCtD
Ethosuximide—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.0144	0.0156	CcSEcCtD
Ethosuximide—Connective tissue disorder—Telbivudine—hepatitis B	0.0137	0.0148	CcSEcCtD
Ethosuximide—Leukopenia—Entecavir—hepatitis B	0.0132	0.0143	CcSEcCtD
Ethosuximide—Sleep disorder—Lamivudine—hepatitis B	0.0131	0.0142	CcSEcCtD
Ethosuximide—Mediastinal disorder—Telbivudine—hepatitis B	0.0125	0.0136	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.0125	0.0135	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0122	0.0132	CcSEcCtD
Ethosuximide—Malnutrition—Telbivudine—hepatitis B	0.0121	0.0131	CcSEcCtD
Ethosuximide—Nervous system disorder—Entecavir—hepatitis B	0.0118	0.0128	CcSEcCtD
Ethosuximide—Skin disorder—Entecavir—hepatitis B	0.0117	0.0127	CcSEcCtD
Ethosuximide—Muscle spasms—Telbivudine—hepatitis B	0.0116	0.0126	CcSEcCtD
Ethosuximide—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0115	0.0125	CcSEcCtD
Ethosuximide—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0114	0.0124	CcSEcCtD
Ethosuximide—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0112	0.0121	CcSEcCtD
Ethosuximide—Somnolence—Entecavir—hepatitis B	0.0107	0.0116	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Entecavir—hepatitis B	0.0104	0.0113	CcSEcCtD
Ethosuximide—Fatigue—Entecavir—hepatitis B	0.0104	0.0112	CcSEcCtD
Ethosuximide—Abdominal pain upper—Lamivudine—hepatitis B	0.0103	0.0112	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0102	0.0111	CcSEcCtD
Ethosuximide—Cramp muscle—Lamivudine—hepatitis B	0.0102	0.0111	CcSEcCtD
Ethosuximide—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.0102	0.0111	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.0101	0.011	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Entecavir—hepatitis B	0.00984	0.0107	CcSEcCtD
Ethosuximide—Nervous system disorder—Telbivudine—hepatitis B	0.00969	0.0105	CcSEcCtD
Ethosuximide—Skin disorder—Telbivudine—hepatitis B	0.0096	0.0104	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.0096	0.0104	CcSEcCtD
Ethosuximide—Abdominal pain—Entecavir—hepatitis B	0.00951	0.0103	CcSEcCtD
Ethosuximide—Abdominal discomfort—Lamivudine—hepatitis B	0.00939	0.0102	CcSEcCtD
Ethosuximide—Pancytopenia—Lamivudine—hepatitis B	0.0093	0.0101	CcSEcCtD
Ethosuximide—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00928	0.0101	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00866	0.00939	CcSEcCtD
Ethosuximide—Asthenia—Entecavir—hepatitis B	0.00863	0.00936	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00853	0.00925	CcSEcCtD
Ethosuximide—Fatigue—Telbivudine—hepatitis B	0.00852	0.00924	CcSEcCtD
Ethosuximide—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00842	0.00913	CcSEcCtD
Ethosuximide—Diarrhoea—Entecavir—hepatitis B	0.00823	0.00893	CcSEcCtD
Ethosuximide—Agranulocytosis—Lamivudine—hepatitis B	0.00815	0.00884	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Telbivudine—hepatitis B	0.00808	0.00876	CcSEcCtD
Ethosuximide—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00803	0.00871	CcSEcCtD
Ethosuximide—Dizziness—Entecavir—hepatitis B	0.00795	0.00863	CcSEcCtD
Ethosuximide—Abdominal pain—Telbivudine—hepatitis B	0.00781	0.00847	CcSEcCtD
Ethosuximide—Connective tissue disorder—Lamivudine—hepatitis B	0.0077	0.00835	CcSEcCtD
Ethosuximide—Vomiting—Entecavir—hepatitis B	0.00765	0.0083	CcSEcCtD
Ethosuximide—Rash—Entecavir—hepatitis B	0.00758	0.00823	CcSEcCtD
Ethosuximide—Dermatitis—Entecavir—hepatitis B	0.00758	0.00822	CcSEcCtD
Ethosuximide—Headache—Entecavir—hepatitis B	0.00754	0.00817	CcSEcCtD
Ethosuximide—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00746	0.00809	CcSEcCtD
Ethosuximide—Erythema multiforme—Lamivudine—hepatitis B	0.00741	0.00804	CcSEcCtD
Ethosuximide—Rash—Adefovir Dipivoxil—hepatitis B	0.0074	0.00803	CcSEcCtD
Ethosuximide—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00739	0.00802	CcSEcCtD
Ethosuximide—Headache—Adefovir Dipivoxil—hepatitis B	0.00735	0.00797	CcSEcCtD
Ethosuximide—CYP3A43—Xenobiotics—CYP2A6—hepatitis B	0.00718	0.0921	CbGpPWpGaD
Ethosuximide—Nausea—Entecavir—hepatitis B	0.00715	0.00775	CcSEcCtD
Ethosuximide—Asthenia—Telbivudine—hepatitis B	0.00709	0.00769	CcSEcCtD
Ethosuximide—Immune system disorder—Lamivudine—hepatitis B	0.00708	0.00768	CcSEcCtD
Ethosuximide—Mediastinal disorder—Lamivudine—hepatitis B	0.00706	0.00766	CcSEcCtD
Ethosuximide—Nausea—Adefovir Dipivoxil—hepatitis B	0.00697	0.00756	CcSEcCtD
Ethosuximide—Malnutrition—Lamivudine—hepatitis B	0.00682	0.0074	CcSEcCtD
Ethosuximide—Diarrhoea—Telbivudine—hepatitis B	0.00676	0.00733	CcSEcCtD
Ethosuximide—Muscle spasms—Lamivudine—hepatitis B	0.00656	0.00712	CcSEcCtD
Ethosuximide—Dizziness—Telbivudine—hepatitis B	0.00653	0.00709	CcSEcCtD
Ethosuximide—Vomiting—Telbivudine—hepatitis B	0.00628	0.00681	CcSEcCtD
Ethosuximide—Rash—Telbivudine—hepatitis B	0.00623	0.00676	CcSEcCtD
Ethosuximide—Dermatitis—Telbivudine—hepatitis B	0.00623	0.00675	CcSEcCtD
Ethosuximide—Headache—Telbivudine—hepatitis B	0.00619	0.00671	CcSEcCtD
Ethosuximide—Leukopenia—Lamivudine—hepatitis B	0.00611	0.00662	CcSEcCtD
Ethosuximide—Nausea—Telbivudine—hepatitis B	0.00587	0.00637	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00577	0.00626	CcSEcCtD
Ethosuximide—Nervous system disorder—Lamivudine—hepatitis B	0.00546	0.00592	CcSEcCtD
Ethosuximide—Skin disorder—Lamivudine—hepatitis B	0.00541	0.00587	CcSEcCtD
Ethosuximide—Anorexia—Lamivudine—hepatitis B	0.00531	0.00576	CcSEcCtD
Ethosuximide—Somnolence—Lamivudine—hepatitis B	0.00495	0.00537	CcSEcCtD
Ethosuximide—Decreased appetite—Lamivudine—hepatitis B	0.00484	0.00525	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00481	0.00521	CcSEcCtD
Ethosuximide—Fatigue—Lamivudine—hepatitis B	0.0048	0.00521	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Lamivudine—hepatitis B	0.00455	0.00494	CcSEcCtD
Ethosuximide—Urticaria—Lamivudine—hepatitis B	0.00442	0.0048	CcSEcCtD
Ethosuximide—Abdominal pain—Lamivudine—hepatitis B	0.0044	0.00477	CcSEcCtD
Ethosuximide—Hypersensitivity—Lamivudine—hepatitis B	0.0041	0.00445	CcSEcCtD
Ethosuximide—Asthenia—Lamivudine—hepatitis B	0.004	0.00433	CcSEcCtD
Ethosuximide—Diarrhoea—Lamivudine—hepatitis B	0.00381	0.00413	CcSEcCtD
Ethosuximide—Dizziness—Lamivudine—hepatitis B	0.00368	0.00399	CcSEcCtD
Ethosuximide—CYP3A5—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00359	0.0461	CbGpPWpGaD
Ethosuximide—Vomiting—Lamivudine—hepatitis B	0.00354	0.00384	CcSEcCtD
Ethosuximide—Rash—Lamivudine—hepatitis B	0.00351	0.00381	CcSEcCtD
Ethosuximide—Dermatitis—Lamivudine—hepatitis B	0.00351	0.0038	CcSEcCtD
Ethosuximide—Headache—Lamivudine—hepatitis B	0.00349	0.00378	CcSEcCtD
Ethosuximide—CYP2E1—CYP2E1 reactions—CYP2A6—hepatitis B	0.00338	0.0433	CbGpPWpGaD
Ethosuximide—Nausea—Lamivudine—hepatitis B	0.00331	0.00359	CcSEcCtD
Ethosuximide—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00298	0.0382	CbGpPWpGaD
Ethosuximide—CYP3A43—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00294	0.0377	CbGpPWpGaD
Ethosuximide—CYP3A7—Xenobiotics—CYP2A6—hepatitis B	0.00289	0.0371	CbGpPWpGaD
Ethosuximide—CYP2E1—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.0025	0.0321	CbGpPWpGaD
Ethosuximide—CYP3A43—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00242	0.031	CbGpPWpGaD
Ethosuximide—CYP3A43—Metapathway biotransformation—AKR1B1—hepatitis B	0.00218	0.028	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—GGT2—hepatitis B	0.00212	0.0272	CbGpPWpGaD
Ethosuximide—CYP2E1—Xenobiotics—CYP2A6—hepatitis B	0.00209	0.0269	CbGpPWpGaD
Ethosuximide—CYP3A5—Xenobiotics—CYP2A6—hepatitis B	0.00209	0.0268	CbGpPWpGaD
Ethosuximide—CYP2E1—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00201	0.0258	CbGpPWpGaD
Ethosuximide—CYP3A5—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00201	0.0258	CbGpPWpGaD
Ethosuximide—CYP3A5—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.0017	0.0218	CbGpPWpGaD
Ethosuximide—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00167	0.0214	CbGpPWpGaD
Ethosuximide—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00155	0.0199	CbGpPWpGaD
Ethosuximide—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00143	0.0184	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—CYP2A6—hepatitis B	0.00128	0.0165	CbGpPWpGaD
Ethosuximide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.0012	0.0154	CbGpPWpGaD
Ethosuximide—CYP3A7—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00118	0.0152	CbGpPWpGaD
Ethosuximide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00116	0.0149	CbGpPWpGaD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hepatitis B	0.00103	0.0132	CbGpPWpGaD
Ethosuximide—CYP3A43—Biological oxidations—GGT1—hepatitis B	0.001	0.0129	CbGpPWpGaD
Ethosuximide—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000973	0.0125	CbGpPWpGaD
Ethosuximide—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000972	0.0125	CbGpPWpGaD
Ethosuximide—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000934	0.012	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—AKR1B1—hepatitis B	0.000878	0.0113	CbGpPWpGaD
Ethosuximide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00087	0.0112	CbGpPWpGaD
Ethosuximide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000868	0.0111	CbGpPWpGaD
Ethosuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—hepatitis B	0.000863	0.0111	CbGpPWpGaD
Ethosuximide—CYP2E1—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000858	0.011	CbGpPWpGaD
Ethosuximide—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000856	0.011	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—GGT2—hepatitis B	0.000853	0.0109	CbGpPWpGaD
Ethosuximide—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00079	0.0101	CbGpPWpGaD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000705	0.00904	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000703	0.00902	CbGpPWpGaD
Ethosuximide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000667	0.00856	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—HNF4A—hepatitis B	0.000659	0.00845	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—AKR1B1—hepatitis B	0.000636	0.00816	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.000634	0.00814	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GGT2—hepatitis B	0.000618	0.00793	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.000617	0.00791	CbGpPWpGaD
Ethosuximide—CACNA1G—NCAM signaling for neurite out-growth—IL6—hepatitis B	0.000599	0.00768	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP2A6—hepatitis B	0.000517	0.00663	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—GGT1—hepatitis B	0.000404	0.00518	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000403	0.00518	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000398	0.00511	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKR1B1—hepatitis B	0.000378	0.00485	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP2A6—hepatitis B	0.000374	0.0048	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.000374	0.00479	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GGT2—hepatitis B	0.000362	0.00465	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000327	0.0042	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000295	0.00378	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GGT1—hepatitis B	0.000292	0.00375	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000292	0.00374	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000287	0.00368	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2A6—hepatitis B	0.000219	0.00282	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—CTNNB1—hepatitis B	0.000201	0.00258	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GOT2—hepatitis B	0.000198	0.00255	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—NFKB1—hepatitis B	0.000195	0.0025	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000174	0.00223	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—IL6—hepatitis B	0.000172	0.0022	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GGT1—hepatitis B	0.000171	0.0022	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GOT1—hepatitis B	0.000171	0.0022	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TGFB1—hepatitis B	0.000163	0.00209	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKR1B1—hepatitis B	0.000152	0.00195	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TNF—hepatitis B	0.000152	0.00195	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GGT2—hepatitis B	0.000146	0.00187	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000136	0.00174	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—IL6—hepatitis B	0.000123	0.00157	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKR1B1—hepatitis B	0.00011	0.00141	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKR1B1—hepatitis B	0.00011	0.00141	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GGT2—hepatitis B	0.000106	0.00136	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GGT2—hepatitis B	0.000105	0.00135	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALB—hepatitis B	9.11e-05	0.00117	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2A6—hepatitis B	8.84e-05	0.00113	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GOT2—hepatitis B	7.99e-05	0.00103	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PTEN—hepatitis B	6.95e-05	0.000892	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GGT1—hepatitis B	6.9e-05	0.000885	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GOT1—hepatitis B	6.9e-05	0.000885	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP2A6—hepatitis B	6.4e-05	0.000821	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2A6—hepatitis B	6.39e-05	0.00082	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GOT2—hepatitis B	5.79e-05	0.000743	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GOT2—hepatitis B	5.78e-05	0.000741	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKR1B1—hepatitis B	5.11e-05	0.000656	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GGT1—hepatitis B	5e-05	0.000641	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GOT1—hepatitis B	5e-05	0.000641	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GOT1—hepatitis B	4.99e-05	0.00064	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GGT1—hepatitis B	4.99e-05	0.00064	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GGT2—hepatitis B	4.9e-05	0.000629	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALB—hepatitis B	3.67e-05	0.000471	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2A6—hepatitis B	2.97e-05	0.000381	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PTEN—hepatitis B	2.8e-05	0.000359	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GOT2—hepatitis B	2.69e-05	0.000345	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALB—hepatitis B	2.66e-05	0.000341	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALB—hepatitis B	2.65e-05	0.00034	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GOT1—hepatitis B	2.32e-05	0.000298	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GGT1—hepatitis B	2.32e-05	0.000298	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PTEN—hepatitis B	2.03e-05	0.00026	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PTEN—hepatitis B	2.02e-05	0.00026	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALB—hepatitis B	1.23e-05	0.000158	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PTEN—hepatitis B	9.41e-06	0.000121	CbGpPWpGaD
